The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The Iowa Cancer Registry provided a detailed look at cancer statistics in Adair County during a zoom call joined by a room ...

Researchers at Keele University have published the first investigation into the variation in the chemical makeup of ...

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.

Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

In patients with biochemical recurrence after prostate cancer surgery, the optimal duration of hormone therapy after salvage radiation therapy has been debated.

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Johnson & Johnson stands second among the most ...

EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval ...